262 related articles for article (PubMed ID: 28718478)
1. GSH-Responsive supramolecular nanoparticles constructed by β-d-galactose-modified pillar[5]arene and camptothecin prodrug for targeted anticancer drug delivery.
Liu X; Shao W; Zheng Y; Yao C; Peng L; Zhang D; Hu XY; Wang L
Chem Commun (Camb); 2017 Jul; 53(61):8596-8599. PubMed ID: 28718478
[TBL] [Abstract][Full Text] [Related]
2. Bifunctional supramolecular prodrug vesicles constructed from a camptothecin derivative with a water-soluble pillar[5]arene for cancer diagnosis and therapy.
Sun G; He Z; Hao M; Xu Z; Hu XY; Zhu JJ; Wang L
Chem Commun (Camb); 2019 Sep; 55(73):10892-10895. PubMed ID: 31436766
[TBL] [Abstract][Full Text] [Related]
3. Construction of drug-drug conjugate supramolecular nanocarriers based on water-soluble pillar[6]arene for combination chemotherapy.
Shao W; Liu X; Sun G; Hu XY; Zhu JJ; Wang L
Chem Commun (Camb); 2018 Aug; 54(68):9462-9465. PubMed ID: 30083687
[TBL] [Abstract][Full Text] [Related]
4. Supramolecular chemotherapeutic drug constructed from pillararene-based supramolecular amphiphile.
Wu D; Li Y; Shen J; Tong Z; Hu Q; Li L; Yu G
Chem Commun (Camb); 2018 Jul; 54(59):8198-8201. PubMed ID: 29975382
[TBL] [Abstract][Full Text] [Related]
5. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
[TBL] [Abstract][Full Text] [Related]
6. Enzyme-responsive fluorescent camptothecin prodrug/polysaccharide supramolecular assembly for targeted cellular imaging and in situ controlled drug release.
Zhang YH; Zhang YM; Sheng X; Wang J; Liu Y
Chem Commun (Camb); 2020 Jan; 56(7):1042-1045. PubMed ID: 31868189
[TBL] [Abstract][Full Text] [Related]
7. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
[TBL] [Abstract][Full Text] [Related]
8. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
[TBL] [Abstract][Full Text] [Related]
10. A supramolecular hybrid material constructed from pillar[6]arene-based host-guest complexation and ZIF-8 for targeted drug delivery.
Yang K; Yang K; Chao S; Wen J; Pei Y; Pei Z
Chem Commun (Camb); 2018 Aug; 54(70):9817-9820. PubMed ID: 30109320
[TBL] [Abstract][Full Text] [Related]
11. Orthogonal Design of a Water-Soluble
Tian X; Zuo M; Niu P; Velmurugan K; Wang K; Zhao Y; Wang L; Hu XY
ACS Appl Mater Interfaces; 2021 Aug; 13(31):37466-37474. PubMed ID: 34314153
[TBL] [Abstract][Full Text] [Related]
12. A theranostic prodrug based on FRET for real-time drug release monitoring in response to biothiols.
Hu Y; Zeng F
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():77-85. PubMed ID: 28024642
[TBL] [Abstract][Full Text] [Related]
13. "AND" logic gate regulated pH and reduction dual-responsive prodrug nanoparticles for efficient intracellular anticancer drug delivery.
Bai L; Wang XH; Song F; Wang XL; Wang YZ
Chem Commun (Camb); 2015 Jan; 51(1):93-6. PubMed ID: 25383506
[TBL] [Abstract][Full Text] [Related]
14. Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy.
Zhang L; Qian M; Cui H; Zeng S; Wang J; Chen Q
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6053-6068. PubMed ID: 33525873
[TBL] [Abstract][Full Text] [Related]
15. Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery.
Qu Y; Chu B; Wei X; Lei M; Hu D; Zha R; Zhong L; Wang M; Wang F; Qian Z
J Control Release; 2019 Feb; 296():93-106. PubMed ID: 30664976
[TBL] [Abstract][Full Text] [Related]
16. Integrating a novel SN38 prodrug into the PEGylated liposomal system as a robust platform for efficient cancer therapy in solid tumors.
Fang T; Dong Y; Zhang X; Xie K; Lin L; Wang H
Int J Pharm; 2016 Oct; 512(1):39-48. PubMed ID: 27544846
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional supramolecular vesicles based on the complex of ferrocenecarboxylic acid capped pillar[5]arene and a galactose derivative for targeted drug delivery.
Chang Y; Hou C; Ren J; Xin X; Pei Y; Lu Y; Cao S; Pei Z
Chem Commun (Camb); 2016 Jul; 52(61):9578-81. PubMed ID: 27387299
[TBL] [Abstract][Full Text] [Related]
18. Redox-responsive nanoparticles based on Chondroitin Sulfate and Docetaxel prodrug for tumor targeted delivery of Docetaxel.
Li Y; Chen X; Ji J; Li L; Zhai G
Carbohydr Polym; 2021 Mar; 255():117393. PubMed ID: 33436222
[TBL] [Abstract][Full Text] [Related]
19. Self-assembling nanowires of an amphiphilic camptothecin prodrug derived from homologous derivative conjugation.
He D; Zhang W; Deng H; Huo S; Wang YF; Gong N; Deng L; Liang XJ; Dong A
Chem Commun (Camb); 2016 Dec; 52(98):14145-14148. PubMed ID: 27869268
[TBL] [Abstract][Full Text] [Related]
20. Reduction-sensitive fluorescence enhanced polymeric prodrug nanoparticles for combinational photothermal-chemotherapy.
Zhang Y; Yang D; Chen H; Lim WQ; Phua FSZ; An G; Yang P; Zhao Y
Biomaterials; 2018 May; 163():14-24. PubMed ID: 29452945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
